Capital Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-54,865
Closed -$1.99M 301
2021
Q1
$1.99M Buy
54,865
+1,052
+2% +$37.4K 0.02% 193
2020
Q4
$1.98M Sell
53,813
-1,483
-3% -$54.4K 0.02% 192
2020
Q3
$1.93M Buy
55,296
+2,390
+5% +$83.8K 0.03% 185
2020
Q2
$1.64M Sell
52,906
-932
-2% -$31.7K 0.02% 184
2020
Q1
$1.67M Sell
53,838
-61,787
-53% -$2.11M 0.03% 170
2019
Q4
$4.3M Sell
115,625
-64,660
-36% -$2.3M 0.06% 145
2019
Q3
$6.15M Sell
180,285
-95,420
-35% -$3.47M 0.09% 128
2019
Q2
$11.3M Sell
275,705
-2,403
-0.9% -$95.4K 0.14% 114
2019
Q1
$11.2M Sell
278,108
-6,071
-2% -$243K 0.14% 113
2018
Q4
$11.8M Sell
284,179
-18,306
-6% -$760K 0.17% 106
2018
Q3
$12.6M Buy
302,485
+3,858
+1% +$149K 0.16% 111
2018
Q2
$10.3M Buy
298,627
+11,737
+4% +$401K 0.13% 118
2018
Q1
$9.66M Buy
286,890
+190
+0.1% +$6.53K 0.13% 121
2017
Q4
$9.85M Sell
286,700
-15,667
-5% -$534K 0.13% 122
2017
Q3
$10.2M Buy
302,367
+1,057
+0.4% +$34K 0.13% 123
2017
Q2
$9.6M Buy
+301,310
New +$9.5M 0.13% 127

Other funds holding PFE

Capital Bank & Trust's PFE Position: Q2 2021 in Review

Capital Bank & Trust sold out of Pfizer (PFE) in Q2 2021, closing a stake of 54,865 shares — an estimated $1.99M sold.

Capital Bank & Trust first reported a position in PFE in Q2 2017 and held it in 16 quarters. The position peaked at $12.6M in Q3 2018. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

  • Capital Bank & Trust reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
  • Capital Bank & Trust sold 54,865 Pfizer shares in Q2 2021, an estimated $1.99M.
  • Capital Bank & Trust first reported a position in Pfizer in Q2 2017 and held it in 16 quarters.
  • Capital Bank & Trust's Pfizer position peaked at $12.6M in Q3 2018.
  • 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.